Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Feb-14 11:36 AM View:  | Federici William J Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 13,500 | $6.80 | $91,800.00 | (100%) 13.5K to 0 | |
| 24-Feb-14 6:09 PM View: | Kollender Richard S Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) Duplicate | 5,321,190 | $3.65 | $19,422,400.00 | (100%) 5.32M to 0 | |
| 25-Feb-14 12:12 PM View: | Roche Robert P Jr Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 13,500 | $6.80 | $91,800.00 | (57%) 23.5K to 10.0K | |
| 25-Feb-14 10:16 AM View: | Marino Michael F III SVP and General Counsel | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 10,992 | $6.80 | $74,745.60 | (100%) 10.99K to 0 | |
| 25-Feb-14 11:46 AM View: | McLaughlin Gerald W. SVP, Chief Commercial Officer | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 144,880 | $6.80 | $985,184.00 | (92%) 156.65K to 11.77K | |
| 25-Feb-14 11:57 AM View: | Yetter Wayne P Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 13,500 | $6.80 | $91,800.00 | (100%) 13.5K to 0 | |
| 25-Feb-14 10:40 AM View: | Sebree Terri B President | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 176,699 | $6.80 | $1,201,550.00 | (100%) 176.7K to 0 | |
| 25-Feb-14 10:31 AM View: | Anido Armando Chief Executive Officer Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 1,270,000 | $6.80 | $8,636,000.00 | (100%) 1.27M to 0 | |
| 24-Feb-14 6:09 PM View: | Quaker Bioventures II Lp 10% Owner | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 5,321,190 | $3.65 | $19,422,400.00 | (100%) 5.32M to 0 | |
| 24-Feb-14 6:58 PM View: | Glaxosmithkline Plc | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 4,168,020 | -- | -- | (100%) 4.17M to 0 | |
| 25-Feb-14 11:25 AM View: | Goldan Keith A. CFO and SVP | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 147,191 | $6.80 | $1,000,900.00 | (89%) 166.07K to 18.88K | |
| 25-Feb-14 11:46 AM View: | McLaughlin Gerald W. SVP, Chief Commercial Officer | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 11,771 | $6.80 | $80,042.80 | (100%) 11.77K to 0 | |
| 24-Feb-14 6:09 PM View: | Kollender Richard S Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 13,500 | $3.65 | $49,275.00 | (< 1%) 5.33M to 5.32M | |
| 25-Feb-14 12:12 PM View: | Roche Robert P Jr Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 10,000 | $6.80 | $68,000.00 | (100%) 10.0K to 0 | |
| 25-Feb-14 11:00 AM View: | Datin James A Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 20,620 | $6.80 | $140,216.00 | (100%) 20.62K to 0 | |
| 25-Feb-14 10:16 AM View: | Marino Michael F III SVP and General Counsel | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 183,492 | $6.80 | $1,247,750.00 | (94%) 194.48K to 10.99K | |
| 25-Feb-14 11:25 AM View: | Goldan Keith A. CFO and SVP | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 18,875 | $6.80 | $128,350.00 | (100%) 18.88K to 0 | |
| 25-Feb-14 3:39 PM View: | Safeguard Scientifics Inc Director 10% Owner | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 5,160,380 | $3.65 | $18,835,400.00 | (100%) 5.16M to 0 | |
| 25-Feb-14 10:40 AM View: | Sebree Terri B President | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 179,182 | $6.80 | $1,218,440.00 | (50%) 355.88K to 176.7K | |
| 25-Feb-14 11:15 AM View: | Cola Michael F Director | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 13,500 | $6.80 | $91,800.00 | (100%) 13.5K to 0 | |
| 24-Feb-14 6:58 PM View: | Glaxosmithkline Plc | Nupathe Inc. (PATH) | 06-Feb-14 | Conversion | 1,500,000 | $2.00 | $3,000,000.00 | 56% 2.67M to 4.17M | |
| 12-Jun-13 2:12 PM View: | Sebree Terri B President | Nupathe Inc. (PATH) | 10-Jun-13 | Grant | 30,000 | -- | -- | 9% 330.57K to 360.57K | |
| 26-Apr-13 1:32 PM View: | Kollender Richard S Director | Nupathe Inc. (PATH) | 24-Apr-13 | Grant | 13,500 | -- | -- | < 1% 5.59M to 5.6M | |
| 29-Apr-13 3:57 PM View: | Cola Michael F Director | Nupathe Inc. (PATH) | 24-Apr-13 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 29-Apr-13 3:58 PM View: | Federici William J Director | Nupathe Inc. (PATH) | 24-Apr-13 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 29-Apr-13 3:59 PM View: | Roche Robert P Jr Director | Nupathe Inc. (PATH) | 24-Apr-13 | Grant | 13,500 | -- | -- | 135% 10.0K to 23.5K | |
| 29-Apr-13 3:57 PM View: | Yetter Wayne P Director | Nupathe Inc. (PATH) | 24-Apr-13 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 26-Apr-13 1:32 PM View: | Quaker Bioventures II Lp 10% Owner | Nupathe Inc. (PATH) | 05-Feb-13 | Conversion | 2,500,000 | $2.00 | $5,000,000.00 | 89% 2.82M to 5.32M | |
| 23-Apr-13 3:28 PM View: | Safeguard Scientifics Inc Director 10% Owner | Nupathe Inc. (PATH) | 04-Feb-13 | Conversion | 2,500,000 | $2.00 | $5,000,000.00 | 95% 2.63M to 5.13M | |
| 20-Feb-13 9:08 AM View: | Bvp Gp LLC 10% Owner | Nupathe Inc. (PATH) | 01-Feb-13 | Conversion | 1,000,000 | -- | -- | 27% 3.77M to 4.77M | |
| 14-Feb-14 3:12 PM View: | Glaxosmithkline Plc 10% Owner | Nupathe Inc. (PATH) | 26-Jan-13 | Conversion | 1,516,810 | -- | -- | 66% 2.3M to 3.82M | |
| 22-Jan-13 10:05 AM View: | Anido Armando Chief Executive Officer Director | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 317,580 | -- | -- | 33% 952.42K to 1.27M | |
| 22-Jan-13 10:06 AM View: | Sebree Terri B President | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 125,000 | -- | -- | 61% 205.57K to 330.57K | |
| 22-Jan-13 10:08 AM View: | Marino Michael F III VP and General Counsel | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 135,000 | -- | -- | 227% 59.48K to 194.48K | |
| 22-Jan-13 10:10 AM View: | McLaughlin Gerald W. VP, ChiefCommercial Officer | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 125,000 | -- | -- | 395% 31.65K to 156.65K | |
| 22-Jan-13 10:07 AM View: | Goldan Keith A. CFO and VP | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 125,000 | -- | -- | 304% 41.07K to 166.07K | |
| 09-Jan-13 6:36 PM View: | Marino Michael F III VP and General Counsel | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 59,484 | -- | -- | 100% 0 to 59.48K | |
| 09-Jan-13 6:39 PM View: | McLaughlin Gerald W. VP, ChiefCommercial Officer | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 31,651 | -- | -- | 100% 0 to 31.65K | |
| 09-Jan-13 6:33 PM View: | Goldan Keith A. CFO and VP | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 36,274 | -- | -- | 757% 4.79K to 41.07K | |
| 09-Jan-13 6:29 PM View: | Anido Armando Chief Executive Officer Director | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 369,095 | -- | -- | 63% 583.33K to 952.42K | |
| 09-Jan-13 6:32 PM View: | Sebree Terri B President | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 37,136 | -- | -- | 22% 168.44K to 205.57K | |
| 17-Oct-12 4:07 PM View: | Bioadvance Ventures L P 10% Owner | Nupathe Inc. (PATH) | 17-Oct-12 | Market Sale | 37,593 | $3.39 | $127,440.00 | (12%) 306.47K to 268.88K | 40% |
| 17-Oct-12 4:07 PM View: | Bioadvance Ventures L P 10% Owner | Nupathe Inc. (PATH) | 16-Oct-12 | Market Sale | 72,407 | $3.29 | $238,219.00 | (19%) 378.88K to 306.47K | 38% |
| 17-Oct-12 4:07 PM View: | Bioadvance Ventures L P 10% Owner | Nupathe Inc. (PATH) | 15-Oct-12 | Market Sale | 113,000 | $3.37 | $380,810.00 | (23%) 491.88K to 378.88K | 40% |
| 19-Sep-11 9:59 AM View: | Roche Robert P Jr Director | Nupathe Inc. (PATH) | 15-Sep-11 | Market Purchase | 10,000 | $2.68 | $26,799.00 | 100% 0 to 10.0K | (24%) |
| 12-Sep-11 9:50 AM View: | Hollingsworth Jane H Chief Executive Officer Director | Nupathe Inc. (PATH) | 09-Sep-11 | Market Purchase | 20,000 | $2.56 | $51,286.00 | 10% 206.08K to 226.08K | (21%) |
| 07-Sep-11 4:18 PM View: | Kurtzman Gary J Director | Nupathe Inc. (PATH) | 07-Sep-11 | Market Purchase | 7,500 | $2.49 | $18,674.20 | 100% 0 to 7.5K | (18%) |
| 13-Aug-10 10:40 AM View: | Bv3 LLC | Nupathe Inc. (PATH) | 11-Aug-10 | Conversion | 760,608 | $1.21 | $917,744.00 | 100% 0 to 760.61K | |
| 13-Aug-10 10:40 AM View: | Bv3 LLC | Nupathe Inc. (PATH) | 11-Aug-10 | Purchase | 27,066 | $10.00 | $270,660.00 | 6% 427.84K to 454.91K | |
| 12-Aug-10 4:42 PM View: | Felker Ezra H. VP Business Development | Nupathe Inc. (PATH) | 11-Aug-10 | Conversion | 433 | -- | -- | 6% 7.49K to 7.92K |
